Tag: biosimilars

29 Dec
Lot-to-Lot Variability in Biologics and Biosimilars: What It Means for Patients and Providers
Simon loxton

Lot-to-Lot Variability in Biologics and Biosimilars: What It Means for Patients and Providers

Lot-to-lot variability is a natural part of biologic and biosimilar manufacturing. Unlike generics, these drugs contain millions of slightly different protein versions in each batch. Learn how this variation is managed, why it doesn't affect safety, and what it means for patients and labs.

View More 12

recent posts

False Advertising in Generics: Legal Risks and Rules You Need to Know
False Advertising in Generics: Legal Risks and Rules You Need to Know

Published on: 7 Feb

Orthostatic Hypotension from Medications: Why You Feel Dizzy When Standing Up
Orthostatic Hypotension from Medications: Why You Feel Dizzy When Standing Up

Published on: 26 Feb

Generational Differences: How Age Shapes Attitudes Toward Generic Medications
Generational Differences: How Age Shapes Attitudes Toward Generic Medications

Published on: 21 Feb

Viral Warts: HPV Infection and How to Remove Them
Viral Warts: HPV Infection and How to Remove Them

Published on: 2 Feb

Warfarin and NSAIDs: Understanding the Increased Bleeding Risk
Warfarin and NSAIDs: Understanding the Increased Bleeding Risk

Published on: 5 Feb

categories

archives

tags